January 2026
1. HIRODE G, Zangneh HF, Cerocchi O, Khalili K, et al
   Utility of Serum Biomarkers in Addition to Ultrasound for Early Detection of Hepatocellular Carcinoma in High-Risk Patients: A Randomized Controlled Trial.
   Gastroenterology. 2026 Jan 20:S0016-5085(25)05993.
   

   >> Share

   
   November 2025
2. KIM NJ, Li M, Vutien P, Mecham B, et al
   Changes in Liver Disease Etiology Support a Lower Alpha-Fetoprotein Threshold for Hepatocellular Carcinoma Screening.
   Gastroenterology. 2025 Nov 14:S0016-5085(25)05906.
   

   >> Share

   
   
3. LOK AS, Ward JW, Chang MH, Cohen C, et al
   Hepatitis B Vaccination: A remarkable success story that must continue.
   Gastroenterology. 2025 Nov 13:S0016-5085(25)06482.
   

   >> Share

   
   August 2025
4. KUSHNER T, Cohen SM, Ahn J, Wong RJ, et al
   AGA Clinical Practice Update on Management of Hepatitis Delta: Commentary.
   Gastroenterology. 2025 Aug 20:S0016-5085(25)05842.
   

   >> Share

   
   July 2025
5. JI Y, Le Bert N, Lai-Hung Wong G, Douglas MW, et al
   The Impact of Hepatitis B Surface Antigen Reduction via Small Interfering RNA Treatment on Natural and Vaccine (BRII-179)-Induced Hepatitis B Virus-Specific Humoral and Cellular Immune Responses.
   Gastroenterology. 2025;169:136-149.
   

   >> Share

   
   February 2025
6. ALI FS, Nguyen MH, Hernaez R, Huang DQ, et al
   AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals.
   Gastroenterology. 2025;168:267-284.
   

   >> Share

   
   January 2025
7. KUMAR N, Chaudhary A
   Comments on "Recompensation of Chronic Hepatitis C-Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination Program".
   Gastroenterology. 2025 Jan 30:S0016-5085(25)00326.
   

   >> Share

   
   November 2024
8. MEZZACAPPA C
   Gastro Digest: The Revised REACH-B Model Predicts Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.
   Gastroenterology. 2024 Nov 30:S0016-5085(24)05756.
   

   >> Share

   
   
9. ZHANG X, Klohn M, Ouwerkerk-Mahadevan S, Jagst M, et al
   A pan-genotypic hepatitis E virus replication inhibitor with high potency in a rat infection model.
   Gastroenterology. 2024 Nov 22:S0016-5085(24)05696.
   

   >> Share

   
   August 2024
10. PREMKUMAR M, Dhiman RK, Duseja A, Mehtani R, et al
    Recompensation of Chronic Hepatitis C-related decompensated cirrhosis following direct-acting antiviral therapy: Prospective Cohort study from an HCV elimination program.
    Gastroenterology. 2024 Aug 22:S0016-5085(24)05359.
    

    >> Share

    
    
11. TRAN CS, Kersten J, Yan J, Breinig M, et al
    Phosphatidylinositol 4-Kinase III Alpha Governs Cytoskeletal Organization for Invasiveness of Liver Cancer Cells.
    Gastroenterology. 2024;167:522-537.
    

    >> Share

    
    July 2024
12. MEZZACAPPA C
    Gastro Digest: Integrated telemedicine to treat HCV through opioid treatment programs.
    Gastroenterology. 2024 Jul 16:S0016-5085(24)05213.
    

    >> Share

    
    June 2024
13. LIAW YF
    Prediction of Clinical Relapse and HBsAg Loss After Cessation of Anti-HBV Therapy.
    Gastroenterology. 2024;166:1193.
    

    >> Share

    
    May 2024
14. GOUTTENOIRE J, Neyts J
    A hepatitis E virus infection model in the Mongolian Gerbil: ready for antiviral and vaccine studies.
    Gastroenterology. 2024 May 23:S0016-5085(24)04938.
    

    >> Share

    
    April 2024
15. GUTIERREZ SANCHEZ LH, Ibrahim SH
    Severe Acute Hepatitis of Unknown Etiology in Children: New Virus or Immune Dysregulation.
    Gastroenterology. 2024 Apr 23:S0016-5085(24)00481.
    

    >> Share

    
    
16. LIU T, He Q, Yang X, Li Y, et al
    An Immunocompetent Mongolian Gerbil Model for Hepatitis E Virus Genotype 1 Infection.
    Gastroenterology. 2024 Apr 5:S0016-5085(24)00364.
    

    >> Share

    
    February 2024
17. TRIVEDI PJ, Hirschfield GM, Adams DH, Vierling JM, et al
    Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts.
    Gastroenterology. 2024 Feb 9:S0016-5085(24)00165.
    

    >> Share

    
    
18. HERMS Q, Fuster-Anglada C, Juanola A
    Pembrolizumab-induced Liver Injury: Beyond Immune-Mediated Hepatitis.
    Gastroenterology. 2024 Feb 4:S0016-5085(24)00133.
    

    >> Share

    
    January 2024
19. PISATURO M, Alessio L, de Pascalis S, Messina V, et al
    A Model to Eliminate Viral Hepatitis Infection in Migrants: A Prospective, Multicenter Study in Southern Italy.
    Gastroenterology. 2024;166:191-193.
    

    >> Share

    
    December 2023
20. LAI L, Rao C, Liu H
    An Unusual Cause of Ascites in a Patient with Hepatitis B.
    Gastroenterology. 2023 Dec 7:S0016-5085(23)05593.
    

    >> Share

    
    November 2023
21. LENS S
    Successful HCV viral cure is not the end of the story.
    Gastroenterology. 2023 Nov 3:S0016-5085(23)05205.
    

    >> Share

    
    October 2023
22. ZHENG D, Fang Z, Sun J
    Which is more clinically relevant: end-of-treatment or off-treatment predictors of hepatitis B relapse and surface antigen loss?
    Gastroenterology. 2023 Oct 25:S0016-5085(23)05196.
    

    >> Share

    
    
23. LIM SG, Tan YC
    Additional Measures After Stopping Nucleoside Analogues in HbeAg-Negative Chronic Hepatitis B: Better But Not Enough.
    Gastroenterology. 2023 Oct 12:S0016-5085(23)05132.
    

    >> Share

    
    
24. DARA L, Ghabril M, Phillips E, Kleiner D, et al
    A 68-year-old woman with unexplained liver enzyme elevation and active chronic hepatitis: Beware of drug induced autoimmune like hepatitis.
    Gastroenterology. 2023 Oct 3:S0016-5085(23)05078.
    

    >> Share

    
    September 2023
25. SONNEVELD MJ, Chiu SM, Park JY, Brakenhoff SM, et al
    Hepatitis B Virus DNA and Hepatitis B e Antigen Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and Hepatitis B Antigen Loss in Hepatitis B e Antigen-Negative Patients Who Discontinued Antiviral Therapy.
    Gastroenterology. 2023 Sep 26:S0016-5085(23)05068.
    

    >> Share

    
    August 2023
26. CONGLY SE, Brahmania M, Coffin CS
    Medicare Part D Spending for Hepatitis B Virus Drugs: Completing the Picture and Extending the Dataset.
    Gastroenterology. 2023 Aug 17:S0016-5085(23)04891.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share